nach oben

Supportive Care in Cancer

Erschienen in:

01.08.2007 | Original Article

The impact of acculturation on the use of traditional Chinese medicine in newly diagnosed Chinese cancer patients

verfasst von: Mark Anthony Ferro, Anne Leis, Richard Doll, Lyren Chiu, Michael Chung, Maria-Cristina Barroetavena

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2007

Einloggen, um Zugang zu erhalten

Abstract

Goals of work

This study assessed the impact of acculturation on the prevalence of traditional Chinese medicine and other complementary and alternative medicine (TCM/CAM) use in newly diagnosed Chinese cancer patients. The individual determinants of TCM/CAM use among patients were also investigated.

Materials and methods

A consecutive sample of Chinese cancer patients treated at the British Columbia Cancer Agency was surveyed at admission using a 15-item questionnaire. Items included TCM/CAM use, sociodemographics, as well as medical and cultural factors. Data were analyzed using bivariate methods including Pearson’s X ² test and Student’s t test. As well, multiple logistic regression was used to obtain the final causal model.

Main results

Of the 230 respondents, 57% completed the survey in Chinese and 94% were immigrants. The average age was 59. Participants had a mean disease duration of approximately 2 months and 79% had already received at least one conventional treatment. Overall, TCM/CAM was used by 47% of respondents. Herbal remedies, vitamins/minerals, and prayer were the most commonly used therapies. Multivariable analysis showed that prior TCM/CAM use (p < 0.001), having received conventional treatment(s) (p = 0.029), and being less acculturated (p = 0.028) were associated with TCM/CAM use.

Conclusions

Prevalence and type of use were found to vary as a function of the degree of acculturation. Health care practitioners would be well advised to discuss TCM/CAM use with their patients, especially those who are less acculturated to Western society, since they are the most likely users of TCM/CAM.

Abdullah AS, Lau Y, Chow LW (2003) Pattern of alternative medicine usage among the Chinese breast cancer patients: implication for service integration. Am J Chin Med 31:649–658PubMedCrossRef

Ashikaga T, Bosompra K, O’Brien P, Nelson L (2002) Use of complementary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer 10:542–548PubMedCrossRef

Beach MC, Price EG, Gary TL, Robinson KA, Gozu A, Palacio A, Smarth C, Jenckes MW, Feuerstein C, Bass EB, Powe NR, Cooper LA (2005) Cultural competence: a systematic review of health care provider educational interventions. Med Care 43:356–373PubMedCrossRef

Boon H, Westlake K, Stewart M, Gray R, Fleshner N, Gavin A, Brown JB, Goel V (2003) Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology 62:849–853PubMedCrossRef

Boon H, Wong J (2004) Botanical medicine and cancer: a review of the safety and efficacy. Expert Opin Pharmacother 5:2485–2501PubMedCrossRef

Cao QZ, Lin ZB (2006) Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sci 78:1457–1463PubMedCrossRef

Chan CW, Hon HC, Chien WT, Lopez V (2004) Social support and coping in Chinese patients undergoing cancer surgery. Cancer Nurs 27:230–236PubMedCrossRef

Chen WT, Bakken S (2004) Breast cancer knowledge assessment in female Chinese immigrants in New York. Cancer Nurs 27:407–412PubMedCrossRef

Chiu L, Balneaves L, Barroetavena MC, Doll R, Leis A (2006) Use of complementary and alternative medicine by Chinese individuals living with cancer in British Columbia. J Complement Integr Med 3:2

10.

Cui Y, Shu XO, Gao Y, Wen W, Ruan ZX, Jin F, Zheng W (2004) Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat 85:263–270PubMedCrossRef

11.

Eng J, Ramsum D, Verhoef M, Guns E, Davison J, Gallagher R (2003) A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther 2:212–216PubMedCrossRef

12.

Fugh-Berman A (2000) Herb-drug interactions. Lancet 355:134–138PubMedCrossRef

13.

Gao Y, Zhou S, Jiang W, Huang M, Dai X (2003) Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest 32:201–215PubMedCrossRef

14.

Gotay CC, Hara W, Issell BF, Maskarinec G (1999) Use of complementary and alternative medicine in Hawaii cancer patients. Hawaii Med J 58:94–98PubMed

15.

Gotay CC, Muraoka M, Holup J (2001) Cultural aspects of cancer prevention and control. In: Kazarian SS, Evans DR (eds) Handbook of cultural psychology. Academic Press, San Diego, CA

16.

Health-Canada (2007) List of Licensed Natural Health Products. Retrieved Jun 4, 2007, from http://www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/lists/listapprnhp-listeapprpsn_e.html

17.

Hislop TG, Deschamps M, Teh C, Jackson C, Tu SP, Yasui Y, Schwartz SM, Kuniyuki A, Taylor V (2003) Facilitators and barriers to cervical cancer screening among Chinese Canadian women. Can J Public Health 94:68–73PubMed

18.

Ho RT, Chan CL, Ho SM (2004) Emotional control in Chinese female cancer survivors. Psychooncology 13:808–817PubMedCrossRef

19.

Jiang J, Slivova V, Sliva D (2006) Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. Int J Oncol 29:695–703PubMed

20.

Jones EG, Kay M (1992) Instrumentation in cross-cultural research. Nurs Res 41:186–188PubMed

21.

Kakai H, Maskarinec G, Shumay DM, Tatsumura Y, Tasaki K (2003) Ethnic differences in choices of health information by cancer patients using complementary and alternative medicine: an exploratory study with correspondence analysis. Soc Sci Med 56:851–862PubMedCrossRef

22.

Kleinman AM (1973) Toward a comparative study of medical systems: an integrated approach to the study of the relationship of medicine and culture. Sci Med Man 1:55–65PubMed

23.

Kronenberg F, Cushman LF, Wade CM, Kalmuss D, Chao MT (2006) Race/ethnicity and women’s use of complementary and alternative medicine in the United States: results of a national survey. Am J Public Health 96:1236–1242PubMedCrossRef

24.

Kwok Y, Ng KF, Li CC, Lam CC, Man RY (2005) A prospective, randomized, double-blind, placebo-controlled study of the platelet and global hemostatic effects of Ganoderma lucidum (Ling-Zhi) in healthy volunteers. Anesth Analg 101:423–426PubMedCrossRef

25.

Lapine A, Wang-Cheng R, Goldstein M, Nooney A, Lamb G, Derse AR (2001) When cultures clash: physician, patient, and family wishes in truth disclosure for dying patients. J Palliat Med 4:475–480PubMedCrossRef

26.

Lee EH, Kim JS, Song MS (2002) Translation and validation of champion’s health belief model scale with Korean women. Cancer Nurs 25:391–395PubMedCrossRef

27.

Lee MM, Chang JS, Jacobs B, Wrensch MR (2002) Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations. Am J Public Health 92:1606–1609PubMedCrossRef

28.

Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D (2000) Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 92:42–47PubMedCrossRef

29.

Li-chun C, I-chuan L (2004) Patterns of complementary therapy use by homebound cancer patients in Taiwan. Appl Nurs Res 17:41–47PubMedCrossRef

30.

Liu JM, Chu HC, Chin YH, Chen YM, Hsieh RK, Chiou TJ, Whang-Peng J (1997) Cross sectional study of use of alternative medicines in Chinese cancer patients. Jpn J Clin Oncol 27:37–41PubMedCrossRef

31.

Lu QY, Jin YS, Zhang Q, Zhang Z, Heber D, Go VL, Li FP, Rao JY (2004) Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer Lett 216:9–20PubMedCrossRef

32.

Mak MH (2001) Awareness of dying: an experience of Chinese patients with terminal cancer. Omega 43:259–279PubMed

33.

Maskarinec G, Shumay DM, Kakai H, Gotay CC (2000) Ethnic differences in complementary and alternative medicine use among cancer patients. J Altern Complement Med 6:531–538PubMed

34.

McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK (2004) Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer 12:454–462PubMedCrossRef

35.

McKay DJ, Bentley JR, Grimshaw RN (2005) Complementary and alternative medicine in gynaecologic oncology. J Obstet Gynaecol Can 27:562–568PubMed

36.

Messias DK, Rubio M (2004) Immigration and health. Annu Rev Nurs Res 22:101–134PubMed

37.

Miller LG (1998) Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 158:2200–2211PubMedCrossRef

38.

National Cancer Institute of Canada (NCIC) (2006) Canadian cancer statistics, 2006. NCIC, Canada

39.

Nonaka Y, Shibata H, Nakai M, Kurihara H, Ishibashi H, Kiso Y, Tanaka T, Yamaguchi H, Abe S (2006) Anti-tumor activities of the antlered form of Ganoderma lucidum in allogeneic and syngeneic tumor-bearing mice. Biosci Biotechnol Biochem 70:2028–2034PubMedCrossRef

40.

Oliffe J, Thorne S, Hislop TG, Armstrong EA (2007) “Truth telling” and cultural assumptions in an era of informed consent. Fam Commun Health 30:5–15

41.

Philip RB (2004) Herbal remedies: the good, the bad, and the ugly. J Complement Integr Med 1:1–11

42.

Pineda MD, White E, Kristal AR, Taylor V (2001) Asian breast cancer survival in the US: a comparison between Asian immigrants, US-born Asian Americans and Caucasians. Int J Epidemiol 30:976–982PubMedCrossRef

43.

Rosner B (2000) Fundamentals of biostatistics, 5th edn. Duxbury, Pacific Grove

44.

Rothman KJ, Greenland S (1998) Modern epidemiology, 2nd edn. Lippincott-Raven, Philadelphia

45.

Salant T, Lauderdale DS (2003) Measuring culture: a critical review of acculturation and health in Asian immigrant populations. Soc Sci Med 57:71–90PubMedCrossRef

46.

Satia-Abouta J, Patterson RE, Kristal AR, Teh C, Tu SP (2002) Psychosocial predictors of diet and acculturation in Chinese American and Chinese Canadian women. Ethn Health 7:21–39PubMedCrossRef

47.

Shen J, Glaspy J (2001) Acupuncture: evidence and implications for cancer supportive care. Cancer Pract 9:147–150PubMedCrossRef

48.

Shen J, Wenger N, Glaspy J, Hays RD, Albert PS, Choi C, Shekelle PG (2000) Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial. JAMA 284:2755–2761PubMedCrossRef

49.

Shih FJ (1996) Concepts related to Chinese patients’ perceptions of health, illness and person: issues of conceptual clarity. Accid Emerg Nurs 4:208–215PubMedCrossRef

50.

Sliva D (2003) Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther 2:358–364PubMedCrossRef

51.

Stanley G, Harvey K, Slivova V, Jiang J, Sliva D (2005) Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells. Biochem Biophys Res Commun 330:46–52PubMedCrossRef

52.

Statistics-Canada (2005) Study: Canada’s visible minority population in 2017 (No. 91-541-XIE). Statistics-Canada, Ottawa

53.

Suinn RM, Ahuna C, Khoo G (1992) The Suinn-Lew Asian Self-Identity Acculturation Scale: concurrent and factorial validation. Educ Psychol Meas 52:1041–1046CrossRef

54.

Tang W, Liu JW, Zhao WM, Wei DZ, Zhong JJ (2006) Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci 80:205–211PubMedCrossRef

55.

Thyagarajan A, Jiang J, Hopf A, Adamec J, Sliva D (2006) Inhibition of oxidative stress-induced invasiveness of cancer cells by Ganoderma lucidum is mediated through the suppression of interleukin-8 secretion. Int J Mol Med 18:657–664PubMed

56.

Tough SC, Johnston DW, Verhoef MJ, Arthur K, Bryant H (2002) Complementary and alternative medicine use among colorectal cancer patients in Alberta, Canada. Altern Ther Health Med 8:54–56, 58–60, 62–54PubMed

57.

Geertz as cited in Turner L (2005) From the local to the global: bioethics and the concept of culture. J Med Philos 30:305–320

58.

Wendler D, Cornelio M (2006) Overcoming language barriers in medical care. Pediatr Blood Cancer 47:747PubMedCrossRef

59.

Xu W, Towers AD, Li P, Collet JP (2006) Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China. Eur J Cancer Care (Engl) 15:397–403CrossRef

Titel: The impact of acculturation on the use of traditional Chinese medicine in newly diagnosed Chinese cancer patients
verfasst von: Mark Anthony Ferro
Anne Leis
Richard Doll
Lyren Chiu
Michael Chung
Maria-Cristina Barroetavena
Publikationsdatum: 01.08.2007
Verlag: Springer-Verlag
Erschienen in: Supportive Care in Cancer / Ausgabe 8/2007
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-007-0285-0

Springer Medizin

The impact of acculturation on the use of traditional Chinese medicine in newly diagnosed Chinese cancer patients